181 related articles for article (PubMed ID: 36633465)
1. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
[TBL] [Abstract][Full Text] [Related]
2. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
[TBL] [Abstract][Full Text] [Related]
3. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
[TBL] [Abstract][Full Text] [Related]
4. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
Carrat F
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Pinyopornpanish K; Al-Yaman W; Butler RS; Carey W; McCullough A; Romero-Marrero C
Am J Gastroenterol; 2021 Nov; 116(11):2258-2269. PubMed ID: 34212895
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
[TBL] [Abstract][Full Text] [Related]
9. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
10. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
[TBL] [Abstract][Full Text] [Related]
11. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Goh MJ; Sinn DH
Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
13. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
14. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis.
Shin S; Lee SH; Lee M; Kim JH; Lee W; Lee HW; Park MS; Park S; Kim TS; Choi DH
Medicine (Baltimore); 2020 Feb; 99(9):e19008. PubMed ID: 32118712
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
Sharpton SR; Loomba R
Hepatology; 2023 Dec; 78(6):1896-1906. PubMed ID: 37013380
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
[TBL] [Abstract][Full Text] [Related]
19. Statin Use and Reduced Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Fatty Liver Disease.
Zou B; Odden MC; Nguyen MH
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):435-444.e6. PubMed ID: 35158055
[TBL] [Abstract][Full Text] [Related]
20. Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data.
Sinn DH; Kang D; Park Y; Kim H; Hong YS; Cho J; Gwak GY
BMC Gastroenterol; 2023 Oct; 23(1):366. PubMed ID: 37880589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]